Bulut I, Yegin Katran Z. Reclassification of NSAID hypersensitivity according to the WAO 2025 guidelines: insights from a cohort of 527 patients. Allergol Immunopathol [Internet]. 2026 Jan. 1 [cited 2026 Apr. 30];54(1):166-71. Available from: https://www.all-imm.com/index.php/aei/article/view/1579